Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Danny V Jeyaraju"'
Autor:
Dana Yehudai, Sanduni U. Liyanage, Rose Hurren, Biljana Rizoska, Mark Albertella, Marcela Gronda, Danny V Jeyaraju, Xiaoming Wang, Samir H. Barghout, Neil MacLean, Thirushi P. Siriwardena, Yulia Jitkova, Paul Targett-Adams, Aaron D. Schimmer
Publikováno v:
Haematologica, Vol 104, Iss 5 (2019)
Mitochondrial DNA encodes 13 proteins that comprise components of the respiratory chain that maintain oxidative phosphorylation. The replication of mitochondrial DNA is performed by the sole mitochondrial DNA polymerase γ. As acute myeloid leukemia
Externí odkaz:
https://doaj.org/article/a3754aeeba0b4a40bc86a29f3f6df762
Autor:
Danny V Jeyaraju, Sheida Hayati, Ann Polonskaia, Maryam Alapa, Manuel Ugidos, Andrew Browne, Alberto Risueño, Patrick Hagner, Vikas Gupta, Moshe Talpaz, Christopher Hernandez, Vincent Chia, Patricia Martin-Regueira, Daniel Lopes de Menezes, Ross La Motte-Mohs, Rajasekhar NVS Suragani, Anita K. Gandhi
Publikováno v:
Blood. 140:3865-3867
Autor:
Aarif Ahsan, Wei Fang, Manuel Ugidos, Danny V Jeyaraju, Pierre Fenaux, Uwe Platzbecker, Olivier Hermine, John B. Porter, Rajasekhar N.V.S. Suragani, Sadanand Vodala, Anita K. Gandhi
Publikováno v:
Blood. 140:8188-8189
Autor:
Danny V Jeyaraju, Maryam Alapa, Aimee O'Donohue, Ross La Motte-Mohs, Isaac W. Boss, Patrick Hagner, Michael Pourdehnad, Michael R. Burgess, William E. Pierceall, Anjan Thakurta
Publikováno v:
Blood. 140:7070-7071
Autor:
Xiaoming Wang, Danny V. Jeyaraju, Marcela Gronda, Dana Yehudai, Sanduni U. Liyanage, Mark Albertella, Thirushi P. Siriwardena, Samir H. Barghout, Biljana Rizoska, Rose Hurren, Yulia Jitkova, Aaron D. Schimmer, Neil MacLean, Paul Targett-Adams
Publikováno v:
Haematologica
Mitochondrial DNA encodes 13 proteins that comprise components of the respiratory chain that maintain oxidative phosphorylation. The replication of mitochondrial DNA is performed by the sole mitochondrial DNA polymerase γ. As acute myeloid leukemia
Autor:
Jammula Sriganesh, Charalampos Kyriakopoulos, Patrick Hagner, Alberto Risueño, Gaurav Jain, Danny V Jeyaraju, Anjan Thakurta, Amit Anand, Daniel Menezes, Christopher Hartl, Aarif Ahsan, Chao Wang, Madhusudhan Reddy, Maryam Alapa, Nathalie Lailler, Prakash Subramanyam, Ann Polonskaia, Kaushik Ghosh
Publikováno v:
Blood. 138:3355-3355
Acute Myeloid Leukemia (AML) is characterized by uncontrolled proliferation of incompletely differentiated myeloid stem/ progenitor cells. Despite recent advances in therapy, high rates of clinical relapse, even in patients who achieve complete remis
Autor:
Neil MacLean, Shawn Brennan, Adam C. Smith, Rose Hurren, Allison Berger, Xiaoming Wang, Razq Hakem, Marcela Gronda, Mark D. Minden, Sara Farshchi Zarabi, Simon Kavanagh, Tary Traore, G. Wei Xu, Aaron D. Schimmer, Emil F. Pai, Samir H. Barghout, Ondrej Halgas, Michael Milhollen, Marc L. Hyer, Parasvi S. Patel, Danny V. Jeyaraju
Publikováno v:
Leukemia. 33:37-51
Acute myeloid leukemia (AML) is an aggressive hematologic malignancy for which new therapeutic approaches are required. One such potential therapeutic strategy is to target the ubiquitin-like modifier-activating enzyme 1 (UBA1), the initiating enzyme
Autor:
Patrick Hagner, Kyle J. MacBeth, C.L. Beach, Dai Yumin, Anjan Thakurta, Wendy L. See, Danny V Jeyaraju, Diana Ronai Dunshee, Jessica C. Jang, Ignazia La Torre, Daniel Menezes, Xiaomin Wang, Keshava Kumar, Barry S. Skikne, Alberto Risueño
Publikováno v:
Blood. 136:33-34
BACKGROUND: CC-486, a DNA hypomethylating agent and epigenetic modifier, is an oral formulation of azacitidine (AZA) that is administered at lower exposures for extended durations (300 mg/day [d] for 14 or 21d/28d cycle) compared with the injectable
Autor:
Mathieu Lupien, Yulia Jitkova, Michael Mullokandov, Helen Loo Yau, Rima Al-awar, James R. Hawley, Rose Hurren, Troy Ketela, S. Kim, Veronique Voisin, Neil MacLean, Daniel D. De Carvalho, Mark D. Minden, Geethu E. Thomas, Val A. Fajardo, Ahmed Aman, Zhenyue Hao, Zaza Khuchua, G. Wei Xu, Gary D. Bader, Richard P. Bazinet, Juan J. Aristizabal Henao, Mingjing Xu, Paul J. LeBlanc, Ayesh K. Seneviratne, Steven M. Claypool, Steven M. Chan, Xiaoming Wang, Atan Gross, Aaron D. Schimmer, Ken D. Stark, David Sharon, Raphaël Chouinard-Watkins, Danny V. Jeyaraju, Caitlin Schafer, Marcela Gronda
Summary Tafazzin (TAZ) is a mitochondrial transacylase that remodels the mitochondrial cardiolipin into its mature form. Through a CRISPR screen, we identified TAZ as necessary for the growth and viability of acute myeloid leukemia (AML) cells. Genet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43b74e60e809d7c98db8697836fef410
https://europepmc.org/articles/PMC7137093/
https://europepmc.org/articles/PMC7137093/
Autor:
Gary D. Bader, Troy Ketela, Veronique Voisin, Danny V. Jeyaraju, Dilshad H. Khan, G. Wei Xu, Sajid A. Marhon, Yulia Jitkova, Michael Mullokandov, Rob C. Laister, Aaron D. Schimmer, Xiaoming Wang, Rose Hurren, Daniel D. De Carvalho, Marcela Gronda, Ayesh K. Seneviratne, Zachary Blatman, Neil MacLean, Mark D. Minden, Atan Gross, Yan Wu
Publikováno v:
Blood. 136(1)
Through a clustered regularly insterspaced short palindromic repeats (CRISPR) screen to identify mitochondrial genes necessary for the growth of acute myeloid leukemia (AML) cells, we identified the mitochondrial outer membrane protein mitochondrial